| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 6460 | 2008 |
| Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on … CG Goetz, W Poewe, O Rascol, C Sampaio, GT Stebbins, C Counsell, ... Movement disorders 19 (9), 1020-1028, 2004 | 2586 | 2004 |
| A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang New England Journal of Medicine 342 (20), 1484-1491, 2000 | 1996 | 2000 |
| Association between early-onset Parkinson's disease and mutations in the parkin gene CB Lücking, A Dürr, V Bonifati, J Vaughan, G De Michele, T Gasser, ... New England Journal of Medicine 342 (21), 1560-1567, 2000 | 1924 | 2000 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ... Movement disorders 22 (1), 41-47, 2007 | 1530 | 2007 |
| The unified Parkinson's disease rating scale (UPDRS): status and recommendations Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease Movement Disorders 18 (7), 738-750, 2003 | 1303 | 2003 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ... Movement disorders 26 (S3), S42-S80, 2011 | 1110 | 2011 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ... New England Journal of Medicine 361 (13), 1268-1278, 2009 | 1050 | 2009 |
| Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL‐PET study AL Whone, RL Watts, AJ Stoessl, M Davis, S Reske, C Nahmias, AE Lang, ... Annals of neurology 54 (1), 93-101, 2003 | 1039 | 2003 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ... Movement Disorders 26 (S3), S2-S41, 2011 | 830 | 2011 |
| Depression rating scales in Parkinson's disease: critique and recommendations A Schrag, P Barone, RG Brown, AFG Leentjens, WM McDonald, ... Movement disorders 22 (8), 1077-1092, 2007 | 790 | 2007 |
| Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily … O Rascol, DJ Brooks, E Melamed, W Oertel, W Poewe, F Stocchi, ... The Lancet 365 (9463), 947-954, 2005 | 787 | 2005 |
| Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study U Sabatini, K Boulanouar, N Fabre, F Martin, C Carel, C Colonnese, ... Brain 123 (2), 394-403, 2000 | 736 | 2000 |
| Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial P Barone, W Poewe, S Albrecht, C Debieuvre, D Massey, O Rascol, ... The Lancet Neurology 9 (6), 573-580, 2010 | 669 | 2010 |
| Development and validation of the unified multiple system atrophy rating scale (UMSARS) GK Wenning, F Tison, K Seppi, C Sampaio, A Diem, F Yekhlef, I Ghorayeb, ... Movement Disorders 19 (12), 1391-1402, 2004 | 622 | 2004 |
| Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of P arkinson's disease JJ Ferreira, R Katzenschlager, BR Bloem, U Bonuccelli, D Burn, ... European journal of neurology 20 (1), 5-15, 2013 | 559 | 2013 |
| The natural history of multiple system atrophy: a prospective European cohort study GK Wenning, F Geser, F Krismer, K Seppi, S Duerr, S Boesch, ... The lancet neurology 12 (3), 264-274, 2013 | 552 | 2013 |
| Evidence‐based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 CG Goetz, W Poewe, O Rascol, C Sampaio Movement disorders: official journal of the Movement Disorder Society 20 (5 …, 2005 | 537 | 2005 |
| Priorities in Parkinson's disease research WG Meissner, M Frasier, T Gasser, CG Goetz, A Lozano, P Piccini, ... Nature reviews Drug discovery 10 (5), 377-393, 2011 | 525 | 2011 |
| Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial S Palfi, JM Gurruchaga, GS Ralph, H Lepetit, S Lavisse, PC Buttery, ... The Lancet 383 (9923), 1138-1146, 2014 | 521 | 2014 |
